Adult Child & Adolescent Psychiatric Services
Important Notice: Our clinic will be closed on Monday, September 7, in observance of Labor Day.
We will reopen on Tuesday, September 8, and resume our regular business hours.
SPRAVATO Treatment
What Is SPRAVATO® (esketamine)?
SPRAVATO™ nasal spray is a different kind of medication taken with an oral antidepressant for adults with treatment-resistant depression – a first in decades approved by the FDA.
What are the uses of SPRAVATO™ ?
SPRAVATO™ is used to treat adults with treatment-resistant depression.
Is SPRAVATO™ FDA Approved
SPRAVATO®, the only FDA-approved nasal spray for adults with treatment-resistant depression, reduces depression symptoms when two or more antidepressants haven't worked. SPRAVATO® can be taken with or without an oral antidepressant.
SPRAVATO™ Treatment at ACAPS
- You will take SPRAVATO® nasal spray yourself, under the supervision ACAPS provider in one of our clinical setting. Your provider will show you how to use the SPRAVATO® nasal spray device.
- ACAPS healthcare provider will tell you how much SPRAVATO® you will take and when you will take it.
- Follow your SPRAVATO® treatment schedule exactly as your healthcare provider tells you to.
- During and after each use of the SPRAVATO® nasal spray device, you will be checked by ACAPS healthcare provider who will decide when you are ready to leave the healthcare setting.
- You will need to plan for a caregiver or family member to drive you home after taking SPRAVATO®.
- If you miss a SPRAVATO® treatment, your healthcare provider may change your dose and treatment schedule.
- Some people taking SPRAVATO® get nausea and vomiting. You should not eat for at least 2 hours before taking SPRAVATO® and not drink liquids at least 30 minutes before taking SPRAVATO®.
- If you take a nasal corticosteroid or nasal decongestant medicine take these medicines at least 1 hour before taking SPRAVATO®.